Thyia: The comfortable and convenient solution to the smear.

在英国，每天有9名女性被诊断出患有宫颈癌。这是9名妇女，母亲，女儿，妻子，女朋友和朋友的生活受到这种疾病的影响。好消息是，99%的宫颈癌是可以通过简单的宫颈癌筛查预防的。然而，三分之一的妇女没有参加宫颈筛查计划，导致20年来宫颈癌发病率最高，特别是年轻妇女，少数民族群体和来自弱势背景的妇女。这就是我们创建Thyia的原因，这是一个远程医疗平台，旨在增强妇女的医疗保健能力，并终结宫颈癌。通过Thyia，女性可以在自己家中舒适地控制自己的宫颈健康，提供方便，舒适和个性化的体验。我们的平台提供了几个特定的创新功能，包括用于患者主导的临床决策支持的AI聊天机器人，指导指南，与GP和NHS宫颈筛查管理系统共享结果的集成，后续转诊，临床医生视频咨询，以及有关宫颈癌、HPV、自我检测和疫苗接种的教育。我们的平台由UKCA认证的拭子支持，因此女性可以自行测试。这种拭子使用的是实验室PCR技术，类似于新冠病毒检测所用的技术，临床证明其灵敏度与传统拭子相同。自1964年在英国引入以来，涂片检测一直没有改变，而正是由于这种停滞，宫颈癌发病率处于20年来的最高水平。在Thyia，我们热衷于通过结合新技术，严格的临床数据和出色的患者支持来改变这一点，以重新设计过时和服务不足的女性健康领域。没有马镫，没有窥镜，只有你。我们可以一起做出改变，让宫颈癌成为过去。

Every day, nine women in the UK are diagnosed with cervical cancer. That is nine women, mothers, daughters, wives, girlfriends, and friends whose lives are impacted by this disease.The good news is that 99% of cervical cancers are preventable with simple cervical cancer screening. However, one in three women doesn't attend the cervical screening programme, leading to the highest cervical cancer rates in 20 years, especially for young women, minority ethnic groups, and those from disadvantaged backgrounds. That's why we're creating Thyia, a telehealth platform designed to empower women's healthcare and put an end to cervical cancer. With Thyia, women can take control of their cervical health from the comfort of their own homes, with a convenient, comfortable, and personal experience.Our platform offers several specific and innovative features, including an AI chatbot for patient-led clinical decision support, instruction guides, integrations for sharing results with GPs and the NHS Cervical Screening Management System, referrals for follow-up, clinician video consultations, and education about cervical cancer, HPV, self-testing and vaccination. Our platform is supported by a UKCA-certified swab so women can test themselves. The swab uses laboratory PCR technology, similar to that used for Covid-19 testing, and is clinically proven to have equal sensitivity to a traditional swab.The smear test hasn't changed since it was introduced in the UK in 1964, and cervical cancer rates are at a 20-year high because of this stagnation. At Thyia, we are passionate about changing this by combining novel technology, rigorous clinical data, and excellent patient support to redesign an outdated and underserved area of women's health. No more stirrups, no more speculums, no one but you. Together, we can make a difference and make cervical cancer a thing of the past.